Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 14, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Using pre-existing microarray datasets to increase experimental power: application to insulin resistance.

Bernie J Daigle1, Alicia Deng, Tracey McLaughlin

  • 1Department of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.

Plos Computational Biology
|April 3, 2010
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

E-cigarette Aerosol Containing Nicotine Increases Aortic Stiffness in Young Mice.

Cardiovascular toxicology·2026
Same author

A large-scale multi-ancestry mitochondrial variant association analysis for cardiometabolic traits.

Nature communications·2026
Same author

Linkage disequilibrium and allelic heterogeneity explain variation in coronary artery disease risk at 9p21 across populations and reduced effect in Africans.

American journal of human genetics·2026
Same author

Using natural language processing to extract carotid stenosis severity from clinical notes to create a nationwide veteran cohort.

JVS-vascular insights·2026
Same author

Exome-wide association study of blood lipids in 1,158,017 individuals from diverse populations.

Nature genetics·2026
Same author

Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma.

The Journal of clinical investigation·2026

This article introduces a new software tool called SAGAT that improves the accuracy of gene expression studies by incorporating data from thousands of existing public experiments, allowing researchers to detect more significant genes without the high cost of performing additional lab tests.

Area of Science:

  • Bioinformatics and computational genomics for insulin resistance research
  • Statistical genetics and gene expression analysis methodologies

Background:

Researchers often struggle with high levels of noise inherent in DNA microarray experiments. Prior work has shown that increasing the number of replicates helps mitigate this technical variability. However, performing many replicates remains expensive and sometimes impossible due to resource constraints. This gap motivated the search for analytical strategies that improve precision without requiring extra laboratory effort. It was already known that vast amounts of microarray data exist within public repositories. That uncertainty drove the development of methods to leverage these existing resources for new studies. No prior work had resolved how to integrate these diverse datasets to inform specific, smaller-scale experiments. This study addresses the challenge of utilizing public archives to enhance the statistical power of individual gene expression investigations.

Purpose Of The Study:

The aim of this study is to present a new, mathematically principled approach for identifying differentially expressed genes in microarray experiments. Researchers often face the challenge of generating noisy data that limits the reliability of gene expression findings. This project seeks to overcome the high costs associated with performing large numbers of experimental replicates. The authors intend to utilize the vast amounts of existing microarray data currently stored in the public domain. They propose that these archived experiments can inform the analysis of new, smaller-scale studies. The motivation is to provide an inexpensive method that increases accuracy without requiring additional laboratory resources. This work addresses the limitation that public data is often ignored by standard gene expression analysis methods. The study ultimately strives to maximize the potential for biological discovery from subtle transcriptional responses in human research.

Keywords:
transcriptional responsegene expression analysisstatistical powerinsulin resistancecomputational biology

Frequently Asked Questions

The researchers propose that the tool reduces uncertainty in individual gene measurements by utilizing observed coexpression relationships from public datasets. This mechanism effectively increases the statistical power of an experiment, allowing for the detection of more significant genes compared to standard analysis methods.

The software, known as the SVD Augmented Gene expression Analysis Tool, functions by leveraging large-scale public microarray archives. It applies a mathematically principled approach to integrate these existing data, thereby enhancing the effective sample size of a specific, smaller study.

The authors state that the method is applicable to any human microarray study. This technical necessity arises because the tool relies on pre-existing human microarray datasets to establish coexpression patterns, which are then used to refine the analysis of new, unpublished data.

Related Experiment Videos

Last Updated: Jun 14, 2026

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Main Methods:

The review approach involved developing a mathematically principled, data-driven software package for gene expression analysis. The investigators utilized observed coexpression relationships derived from extensive public microarray archives. They tested this computational framework on three well-replicated human datasets to assess performance. The team then applied the tool to unpublished data investigating transcriptional responses related to insulin resistance. To validate the findings, they performed quantitative polymerase chain reaction on a subset of identified genes. The researchers compared the number of significant genes detected before and after applying their computational augmentation. They calculated the effective sample size increase to quantify the gain in statistical power. Finally, they conducted pathway analysis to identify coherent biological changes across the investigated conditions.

Main Results:

The strongest finding indicates that the tool increased effective sample sizes by as many as 2.72 arrays in human datasets. Application to insulin resistance data resulted in a 50% increase in the number of significant genes detected. The researchers evaluated 11 genes using quantitative polymerase chain reaction to confirm the computational predictions. All 11 genes showed consistent directions of expression change during this experimental validation. Statistical significance was confirmed for three of these genes through the laboratory testing process. The analysis revealed coherent biological changes in three specific pathways: inflammation, differentiation, and fatty acid synthesis. These results further the molecular understanding of a type 2 diabetes risk factor. The findings demonstrate that the software maximizes discovery potential from subtle transcriptional responses.

Conclusions:

The authors propose that their software tool effectively maximizes biological discovery from subtle transcriptional responses. They suggest that integrating public data improves the detection of significant genes in new studies. The team reports that their approach provides a mathematically principled way to reduce measurement uncertainty. They demonstrate that their method remains applicable to any human microarray study. The researchers highlight that their tool revealed coherent changes in inflammation, differentiation, and fatty acid synthesis pathways. They note that experimental validation via quantitative polymerase chain reaction confirmed the direction of expression changes for all tested genes. The investigators claim their software package is freely available for immediate use by the scientific community. They conclude that this strategy offers a viable path to increase experimental power without additional laboratory costs.

The researchers use public microarray datasets as a data-driven source to augment the power of new experiments. This secondary data acts as a reference to identify coexpression relationships, which helps in filtering out noise from the primary, smaller-scale experimental results.

The team measured the impact of their tool by calculating the increase in effective sample sizes, which reached as many as 2.72 arrays. They also quantified the improvement in gene detection, observing a 50% increase in significant genes identified in their insulin resistance study.

The researchers suggest that their tool maximizes the potential for biological discovery. They propose that by uncovering subtle transcriptional responses, the software aids in understanding complex conditions like type 2 diabetes, specifically regarding pathways such as inflammation and fatty acid synthesis.